The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study
Open accessAbstract
Importance: The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health Organization (WHO) Global Action Plan on Non-Communicable Diseases. To determine if these commitments have resulted in improved cancer control, quantitative assessments of the cancer burden are required. Objective: To assess the burden for 29 cancer groups over time to provide a framework for policy discussion, resource allocation, and research focus. Evidence Review: Cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) were evaluated for 195 countries and territories by age and sex using the Global Burden of Disease study estimation methods. Levels and trends were analyzed over time, as well as by the Sociodemographic Index (SDI). Changes in incident cases were categorized by changes due to epidemiological vs demographic transition. Findings: In 2016, there were 17.2 million cancer cases worldwide and 8.9 million deaths. Cancer cases increased by 28% between 2006 and 2016. The smallest increase was seen in high SDI countries. Globally, population aging contributed 17%; population growth, 12%; and changes in age-specific rates, -1% to this change. The most common incident cancer globally for men was prostate cancer (1.4 million cases). The leading cause of cancer deaths and DALYs was tracheal, bronchus, and lung cancer (1.2 million deaths and 25.4 million DALYs). For women, the most common incident cancer and the leading cause of cancer deaths and DALYs was breast cancer (1.7 million incident cases, 535 000 deaths, and 14.9 million DALYs). In 2016, cancer caused 213.2 million DALYs globally for both sexes combined. Between 2006 and 2016, the average annual age-standardized incidence rates for all cancers combined increased in 130 of 195 countries or territories, and the average annual age-standardized death rates decreased within that timeframe in 143 of 195 countries or territories. Conclusions and Relevance: Large disparities exist between countries in cancer incidence, deaths, and associated disability. Scaling up cancer prevention and ensuring universal access to cancer care are required for health equity and to fulfill the global commitments for noncommunicable disease and cancer control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationGlobal Burden of Disease Cancer Collaboration, Fitzmaurice, C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., Brenner, H., Dicker, D. J., Chimed-Orchir, O., Dandona, R., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.5688 · Cited by 6,215
Self-citationNaghavi, M., Abajobir, A. A., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Aboyans, V., Adetokunboh, O., Afshin, A., Agrawal, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32152-9 · Cited by 4,821
Self-citationThe Global Burden of Cancer 2013
Fitzmaurice, C., Dicker, D., Pain, A., Hamavid, H., Moradi-Lakeh, M., MacIntyre, M. F., Allen, C., Hansen, G., Woodbrook, R., Wolfe, C., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0735 · Cited by 2,707
Self-citationGakidou, E., Afshin, A., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulle, A. M., Abera, S. F., Aboyans, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32366-8 · Cited by 2,406
Self-citationHay, S. I., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32130-x · Cited by 2,083
Self-citationGlobal Burden of Disease Liver Cancer Collaboration, Akinyemiju, T., Abera, S., Ahmed, M., Alam, N., Alemayohu, M. A., Allen, C., Al-Raddadi, R., Alvis-Guzman, N., Amoako, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3055 · Cited by 1,987
Self-citationWorldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis
Vaccarella, S., Franceschi, S., Bray, F., Wild, C. P., Plummer, M., & Dal Maso, L. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1604412 · Cited by 1,145
Ryerson, A. B., Eheman, C. R., Altekruse, S. F., Ward, J. W., Jemal, A., Sherman, R. L., Henley, S. J., Holtzman, D., Lake, A., Noone, A., et al. (2016) · Cancer · doi:10.1002/cncr.29936 · Cited by 945
Global Effects of Smoking, of Quitting, and of Taxing Tobacco
Jha, P., & Peto, R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1308383 · Cited by 843
Wang, H., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Abraha, H. N., Abu-Raddad, L. J., Abu-Rmeileh, N. M. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31833-0 · Cited by 801
Self-citationModeling causes of death: an integrated approach using CODEm
Foreman, K. J., Lozano, R., Lopez, A. D., & Murray, C. J. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-1 · Cited by 564
Self-citationVaccarella, S., Lortet-Tieulent, J., Plummer, M., Franceschi, S., & Bray, F. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.04.024 · Cited by 497
Fullman, N., Barber, R. M., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32336-x · Cited by 377
Self-citationCancer incidence and mortality attributable to alcohol consumption
Praud, D., Rota, M., Rehm, J., Shield, K., Zatoński, W., Hashibe, M., La Vecchia, C., & Boffetta, P. (2016) · International Journal of Cancer · doi:10.1002/ijc.29890 · Cited by 218 · cited 1×
“Breast 1702 (1629-1801) 20 (15-22) 1682 (1608-1780) 0.”
Saving the World’s Women from Cervical Cancer
Tsu, V. D., & Jerónimo, J. (2016) · New England Journal of Medicine · doi:10.1056/nejmp1604113 · Cited by 99
Offline: NCDs—why are we failing?
Horton, R. C. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31919-0 · Cited by 41
Cited by
Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Abate, D., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdel-Rahman, O., Abdelalim, A., Abdoli, A., Abdollahpour, I., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2019.2996 · Cited by 2,501
Self-citationGlobal Burden of Disease 2019 Cancer Collaboration, Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., Henrikson, H. J., Lu, D., Pennini, A., et al. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2021.6987 · Cited by 2,026
Self-citationArmstrong, A. J., Szmulewitz, R. Z., Petrylak, D. P., Holzbeierlein, J., Villers, A., Azad, A., Alcaraz, A., Alekseev, B., Iguchi, T., Shore, N. D., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00799 · Cited by 1,217
Key steps for effective breast cancer prevention
Britt, K. L., Cuzick, J., & Phillips, K.-A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0266-x · Cited by 992
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Falzone, L., Salomone, S., & Libra, M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01300 · Cited by 908
Metadata
- Authors
- Global Burden of Disease Cancer Collaboration, Fitzmaurice, C., Akinyemiju, T. F., Al Lami, F. H., Alam, T., Alizadeh-Navaei, R., Allen, C., Alsharif, U., Alvis-Guzman, N., Amini, E., Anderson, B. O., Aremu, O., Artaman, A., Asgedom, S. W., Assadi, R., Atey, T. M., Avila-Burgos, L., Awasthi, A., Ba Saleem, H. O., Barac, A., Bennett, J. R., Bensenor, I. M., Bhakta, N., Brenner, H., Cahuana-Hurtado, L., Castañeda-Orjuela, C. A., Catalá-López, F., Choi, J.-Y. J., Christopher, D. J., Chung, S.-C., Curado, M. P., Dandona, L., Dandona, R., das Neves, J., Dey, S., Dharmaratne, S. D., Doku, D. T., Driscoll, T. R., Dubey, M., Ebrahimi, H., Edessa, D., El-Khatib, Z., Endries, A. Y., Fischer, F., Force, L. M., Foreman, K. J., Gebrehiwot, S. W., Gopalani, S. V., Grosso, G., Gupta, R., Gyawali, B., Hamadeh, R. R., Hamidi, S., Harvey, J., Hassen, H. Y., Hay, R. J., Hay, S. I., Heibati, B., Hiluf, M. K., Horita, N., Hosgood, H. D., Ilesanmi, O. S., Innos, K., Islami, F., Jakovljevic, M. B., Johnson, S. C., Jonas, J. B., Kasaeian, A., Kassa, T. D., Khader, Y. S., Khan, E. A., Khan, G., Khang, Y.-H., Khosravi, M. H., Khubchandani, J., Kopec, J. A., Kumar, G. A., Kutz, M., Lad, D. P., Lafranconi, A., Lan, Q., Legesse, Y., Leigh, J., Linn, S., Lunevicius, R., Majeed, A., Malekzadeh, R., Malta, D. C., Mantovani, L. G., McMahon, B. J., Meier, T., Melaku, Y. A., Melku, M., Memiah, P., Mendoza, W., Meretoja, T. J., Mezgebe, H. B., Miller, T. R., Mohammed, S., Mokdad, A. H., Moosazadeh, M., Moraga, P., Mousavi, S. M., Nangia, V., Nguyen, C. T., Nong, V. M., Ogbo, F. A., Olagunju, A. T., PA, M., Park, E.-K., Patel, T., Pereira, D. M., Pishgar, F., Postma, M. J., Pourmalek, F., Qorbani, M., Rafay, A., Rawaf, S., Rawaf, D. L., Roshandel, G., Safiri, S., Salimzadeh, H., Sanabria, J. R., Santric Milicevic, M. M., Sartorius, B., Satpathy, M., Sepanlou, S. G., Shackelford, K. A., Shaikh, M. A., Sharif-Alhoseini, M., She, J., Shin, M.-J., Shiue, I., Shrime, M. G., Sinke, A. H., Sisay, M., Sligar, A., Sufiyan, M. B., Sykes, B. L., Tabarés-Seisdedos, R., Tessema, G. A., Topor-Madry, R., Tran, T. T., Tran, B. X., Ukwaja, K. N., Vlassov, V. V., Vollset, S. E., Weiderpass, E., Williams, H. C., Yimer, N. B., Yonemoto, N., Younis, M. Z., Murray, C. J. L., & Naghavi, M.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2018-11-01
- Volume
- 4
- Issue
- 11
- Pages
- 1553
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2991564522
- Cited by
- 1,518
- References
- 18
- FWCI
- 76.08
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.